| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Challenging Cases in Urothelial Cancer1
|
Soloway, Mark S.
|
|
|
6 |
1 |
p. 91-92
|
artikel
|
| 2 |
Chemotherapy Plus Immune Check-Point Inhibitors in Metastatic Bladder Cancer
|
Soares, Adriana
|
|
|
6 |
1 |
p. 1-8
|
artikel
|
| 3 |
Clinical Trials Corner
|
Agarwal, Piyush K.
|
|
|
6 |
1 |
p. 93-95
|
artikel
|
| 4 |
Docetaxel with or without Ramucirumab after Platinum-Based Chemotherapy and Checkpoint Inhibitors in Advanced Urothelial Carcinoma: A Pre-Specified Subgroup Analysis from the Phase 3 RANGE Trial
|
Drakaki, Alexandra
|
|
|
6 |
1 |
p. 43-52
|
artikel
|
| 5 |
Does 5-alpha Reductase Inhibitor Use Improve The Efficacy of Intravesical Bacille Calmette-Guérin (BCG) for Non-muscle Invasive Bladder Cancer?
|
Al-Hogbani, Mofarej
|
|
|
6 |
1 |
p. 63-69
|
artikel
|
| 6 |
Implementation of a Reduced Opioid Utilization Protocol for Radical Cystectomy
|
Greenberg, Daniel R.
|
|
|
6 |
1 |
p. 33-42
|
artikel
|
| 7 |
Intravesical Coxsackievirus A21 Therapy for Non-Muscle Invasive Bladder Cancer
|
Messing, Edward
|
|
|
6 |
1 |
p. 97-98
|
artikel
|
| 8 |
Lifestyle and Non-muscle Invasive Bladder Cancer Recurrence, Progression, and Mortality: Available Research and Future Directions
|
Zuniga, Kyle B.
|
|
|
6 |
1 |
p. 9-23
|
artikel
|
| 9 |
Limited Stage Small Cell Bladder Cancer: Outcomes of a Contemporary Cohort
|
Grigg, Claud M.
|
|
|
6 |
1 |
p. 83-90
|
artikel
|
| 10 |
Plasmacytoid Urothelial Carcinoma: Response to Chemotherapy and Oncologic Outcomes
|
Diamantopoulos, Leonidas N.
|
|
|
6 |
1 |
p. 71-81
|
artikel
|
| 11 |
Salvage Hyperthermic Gemcitabine and Docetaxel Combination Chemotherapy After BCG Failure in Non-Muscle Invasive Bladder Cancer Patients
|
Rao, Mounica Y.
|
|
|
6 |
1 |
p. 25-32
|
artikel
|
| 12 |
Statins are Associated with Reduced Overall and Cancer-Specific Mortality in Patients Undergoing Radical Cystectomy for Bladder Cancer
|
Wissing, Michel D.
|
|
|
6 |
1 |
p. 53-62
|
artikel
|
Tijdschrift beschrijving